Advances in gene-based vaccine platforms to address the COVID-19 pandemic.
Journal Information
Full Title: Adv Drug Deliv Rev
Abbreviation: Adv Drug Deliv Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Interests None."
Funding Disclosure
Evidence found in paper:
"AcknowledgementsThis work was supported in part by the National Sciences and Engineering Research Council of Canada [grant number 391457], Mitacs Canada, CONACYT Mexico, and Taibah University, Saudi Arabia."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025